Keratinization-associated miR-7 and miR-21 regulate tumor suppressor reversion-inducing cysteine-rich protein with kazal motifs (RECK) in oral cancer

Journal of Biological Chemistry

Volumn 287, Issue 35, 2012, Pages 29261-29272

  Jung, Hyun Min ^a   Phillips, Brittany L ^a   Patel, Rushi S ^a   Cohen, Donald M ^a   Jakymiw, Andrew ^a,c   Kong, William W ^b   Cheng, Jin Q ^b   Chan, Edward K L ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF DENTISTRY   (United States)

^b H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^c MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL PROCESS; CANCER RESEARCH; CELL DENSITY; EXPRESSION PATTERNS; EXPRESSION PROFILING; EXTERNAL STIMULUS; IN-VITRO; INVERSE CORRELATION; MAJOR FACTORS; MICRORNAS; NON-CODING RNAS; ORAL CANCER; ORAL CANCER PATIENTS; ORTHOTOPIC; RADAR CHART; SERUM CONCENTRATION; SQUAMOUS CELL CARCINOMA; TRYPSINIZATION; TUMOR SUPPRESSOR GENES; TUMOR SUPPRESSORS;

AMINO ACIDS; DISEASES; GENE EXPRESSION; GRAFTS; RNA; TUMORS;

DIAGNOSIS;

CYSTEINE; MICRORNA; MICRORNA 21; MICRORNA 7; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL; CANCER PATIENT; CANCER PROGNOSIS; CANCER STAGING; CELL DENSITY; CLINICAL ARTICLE; CLINICAL FEATURE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORRELATION ANALYSIS; GENE ACTIVITY; GENE EXPRESSION; GENE FUNCTION; GENETIC REGULATION; GENETIC TRANSFECTION; HISTOLOGY; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN TISSUE; IN VITRO STUDY; KERATINIZATION; MOUSE; MOUTH SQUAMOUS CELL CARCINOMA; NONHUMAN; PRIORITY JOURNAL; PROTEIN MOTIF; RECK GENE; RNA ANALYSIS; TUMOR SUPPRESSOR GENE;

ADULT; AGED; ANIMALS; GENE EXPRESSION REGULATION, NEOPLASTIC; GPI-LINKED PROTEINS; HEK293 CELLS; HELA CELLS; HUMANS; MALE; MICE; MICE, INBRED NOD; MICE, SCID; MICRORNAS; MIDDLE AGED; MOUTH NEOPLASMS; NEOPLASM TRANSPLANTATION; RNA, NEOPLASM; TRANSCRIPTOME; TRANSPLANTATION, HETEROLOGOUS; TUMOR SUPPRESSOR PROTEINS;

EID: 84865475867     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M112.366518     Document Type: Article

References (55)

1. Scully, C., and Felix, D. H. (2006) Oral medicine. Update for the dental practitioner oral cancer. Br. Dent. J. 200, 13-17
2. Jemal, A., Tiwari, R. C., Murray, T., Ghafoor, A., Samuels, A., Ward, E., Feuer, E. J., and Thun, M. J. (2004) Cancer statistics, 2004. CA. Cancer J. Clin. 54, 8-29
3. Lin, W. H., Chen, I. H., Wei, F. C., Huang, J. J., Kang, C. J., Hsieh, L. L., Wang, H. M., and Huang, S. F. (2011) Clinical significance of preoperative squamous cell carcinoma antigen in oral-cavity squamous cell carcinoma. Laryngoscope 121, 971-977
4. Méndez, E., Houck, J. R., Doody, D. R., Fan, W., Lohavanichbutr, P., Rue, T. C., Yueh, B., Futran, N. D., Upton, M. P., Farwell, D. G., Heagerty, P. J., Zhao, L. P., Schwartz, S. M., and Chen, C. (2009) A genetic expression profile associated with oral cancer identifies a group of patients at high risk of poor survival. Clin. Cancer Res. 15, 1353-1361
5. Chung, C. H., Parker, J. S., Karaca, G., Wu, J., Funkhouser, W. K., Moore, D., Butterfoss, D., Xiang, D., Zanation, A., Yin, X., Shockley, W. W., Weissler, M. C., Dressler, L. G., Shores, C. G., Yarbrough, W. G., and Perou, C. M. (2004) Molecular classification of head and neck squamous cell carcinomas using patterns of gene expression. Cancer Cell 5, 489-500
6. Casiglia, J., and Woo, S. B. (2001) A comprehensive review of oral cancer. Gen. Dent. 49, 72-82
7. Bartel, D. P. (2009) MicroRNAs. Target recognition and regulatory functions. Cell 136, 215-233
8. Friedman, R. C., Farh, K. K., Burge, C. B., and Bartel, D. P. (2009) Most mammalian mRNAs are conserved targets of microRNAs. Genome Res. 19, 92-105
9. Garzon, R., Marcucci, G., and Croce, C. M. (2010) Targeting microRNAs in cancer. Rationale, strategies and challenges. Nat. Rev. Drug Discov. 9, 775-789
10. Bragulla, H. H., and Homberger, D. G. (2009) Structure and functions of keratin proteins in simple, stratified, keratinized and cornified epithelia. J. Anat. 214, 516-559
11. Kobayashi, T., Kishimoto, J., Ge, Y., Jin, W., Hudson, D. L., Ouahes, N., Ehama, R., Shinkai, H., and Burgeson, R. E. (2001) A novel mechanism of matrix metalloproteinase-9 gene expression implies a role for keratinization. EMBO Rep. 2, 604-608
12. Coussens, L. M., Fingleton, B., and Matrisian, L. M. (2002) Matrix metalloproteinase inhibitors and cancer. Trials and tribulations. Science 295, 2387-2392
13. Oh, J., Takahashi, R., Kondo, S., Mizoguchi, A., Adachi, E., Sasahara, R. M., Nishimura, S., Imamura, Y., Kitayama, H., Alexander, D. B., Ide, C., Horan, T. P., Arakawa, T., Yoshida, H., Nishikawa, S., Itoh, Y., Seiki, M., Itohara, S., Takahashi, C., and Noda, M. (2001) The membrane-anchored MMP inhibitor RECK is a key regulator of extracellular matrix integrity and angiogenesis. Cell 107, 789-800
14. Takahashi, C., Sheng, Z., Horan, T. P., Kitayama, H., Maki, M., Hitomi, K., Kitaura, Y., Takai, S., Sasahara, R. M., Horimoto, A., Ikawa, Y., Ratzkin, B. J., Arakawa, T., and Noda, M. (1998) Regulation of matrix metalloproteinase-9 and inhibition of tumor invasion by the membrane-anchored glycoprotein RECK. Proc. Natl. Acad. Sci. U.S.A. 95, 13221-13226
15. Furumoto, K., Arii, S., Mori, A., Furuyama, H., Gorrin Rivas, M. J., Nakao, T., Isobe, N., Murata, T., Takahashi, C., Noda, M., and Imamura, M. (2001) RECK gene expression in hepatocellular carcinoma: correlation with invasion-related clinicopathological factors and its clinical significance. Reverse-inducin, g-cysteine-rich protein with Kazal motifs. Hepatology 33, 189-195
16. Namwat, N., Puetkasichonpasutha, J., Loilome, W., Yongvanit, P., Techasen, A., Puapairoj, A., Sripa, B., Tassaneeyakul, W., Khuntikeo, N., and Wongkham, S. (2011) Down-regulation of reversion-inducing, cysteine-rich protein with Kazal motifs (RECK) is associated with enhanced expression of matrix metalloproteinases and cholangiocarcinoma metastases. J. Gastroenterol. 46, 664-675
17. Song, S. Y., Son, H. J., Nam, E., Rhee, J. C., and Park, C. (2006) Expression of reversion-inducing, cysteine-rich protein with Kazal motifs (RECK) as a prognostic indicator in gastric cancer. Eur. J. Cancer 42, 101-108
18. Takeuchi, T., Hisanaga, M., Nagao, M., Ikeda, N., Fujii, H., Koyama, F., Mukogawa, T., Matsumoto, H., Kondo, S., Takahashi, C., Noda, M., and Nakajima, Y. (2004) The membrane-anchored matrix metalloproteinase (MMP) regulator RECK in combination with MMP-9 serves as an informative prognostic indicator for colorectal cancer. Clin. Cancer Res. 10, 5572-5579
19. Masui, T., Doi, R., Koshiba, T., Fujimoto, K., Tsuji, S., Nakajima, S., Koizumi, M., Toyoda, E., Tulachan, S., Ito, D., Kami, K., Mori, T., Wada, M., Noda, M., and Imamura, M. (2003) RECK expression in pancreatic cancer. Its correlation with lower invasiveness and better prognosis. Clin. Cancer Res. 9, 1779-1784
20. Eisen, M. B., Spellman, P. T., Brown, P. O., and Botstein, D. (1998) Cluster analysis and display of genome-wide expression patterns. Proc. Natl. Acad. Sci. U.S.A. 95, 14863-14868
21. Saldanha, A. J. (2004) Java Treeview. Extensible visualization of microarray data. Bioinformatics 20, 3246-3248
22. Cattani, P., Siddu, A., D'Onghia, S., Marchetti, S., Santangelo, R., Vellone, V. G., Zannoni, G. F., and Fadda, G. (2009) RNA (E6 and E7) assays versus DNA (E6 and E7) assays for risk evaluation for women infected with human papillomavirus. J. Clin. Microbiol. 47, 2136-2141
23. Cattani, P., Zannoni, G. F., Ricci, C., D'Onghia, S., Trivellizzi, I. N., Di Franco, A., Vellone, V. G., Durante, M., Fadda, G., Scambia, G., Capelli, G., and De Vincenzo, R. (2009) Clinical performance of human papillomavirus E6 and E7 mRNA testing for high-grade lesions of the cervix. J. Clin. Microbiol. 47, 3895-3901
24. Lian, S. L., Li, S., Abadal, G. X., Pauley, B. A., Fritzler, M. J., and Chan, E. K. (2009) The C-terminal half of human Ago2 binds to multiple GW-rich regions of GW182 and requires GW182 to mediate silencing. RNA 15, 804-813
25. Li, S., Lian, S. L., Moser, J. J., Fritzler, M. L., Fritzler, M. J., Satoh, M., and Chan, E. K. (2008) Identification of GW182 and its novel isoformTNGW1 as translational repressors in Ago2-mediated silencing. J. Cell Sci. 121, 4134-4144
26. Jakymiw, A., Patel, R. S., Deming, N., Bhattacharyya, I., Shah, P., Lamont, R. J., Stewart, C. M., Cohen, D. M., and Chan, E. K. (2010) Overexpression of dicer as a result of reduced let-7 MicroRNA levels contributes to increased cell proliferation of oral cancer cells. Genes Chromosomes Cancer 49, 549-559
27. Benjamini, Y., and Hochberg, Y. (1995) Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. R. Stat. Soc. 57, 289-300
28. Chen, C., Zhang, Y., Zhang, L., Weakley, S. M., and Yao, Q. (2011) MicroRNA-196. Critical roles and clinical applications in development and cancer. J. Cell Mol. Med. 15, 14-23
29. Yanaihara, N., Caplen, N., Bowman, E., Seike, M., Kumamoto, K., Yi, M., Stephens, R. M., Okamoto, A., Yokota, J., Tanaka, T., Calin, G. A., Liu, C. G., Croce, C. M., and Harris, C. C. (2006) Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell 9, 189-198
30. Gao, W., Shen, H., Liu, L., Xu, J., Xu, J., and Shu, Y. (2011) MiR-21 overexpression in human primary squamous cell lung carcinoma is associated with poor patient prognosis. J. Cancer Res. Clin. Oncol. 137, 557-566
31. Chan, S. H., Wu, C. W., Li, A. F., Chi, C. W., and Lin, W. C. (2008) miR-21 microRNA expression in human gastric carcinomas and its clinical association. Anticancer Res. 28, 907-911
32. Yan, L. X., Huang, X. F., Shao, Q., Huang, M. Y., Deng, L., Wu, Q. L., Zeng, Y. X., and Shao, J. Y. (2008) MicroRNA miR-21 overexpression in human breast cancer is associated with advanced clinical stage, lymph node metastasis and patient poor prognosis. RNA 14, 2348-2360
33. Hatta, M., Matsuzaki, T., Morioka, Y., Yoshida, Y., and Noda, M. (2009) Density- and serum-dependent regulation of the RECK tumor suppressor in mouse embryo fibroblasts. Cell Signal. 21, 1885-1893
34. Morioka, Y., Monypenny, J., Matsuzaki, T., Shi, S., Alexander, D. B., Kitayama, H., and Noda, M. (2009) The membrane-anchored metalloproteinase regulator RECK stabilizes focal adhesions and anterior-posterior polarity in fibroblasts. Oncogene 28, 1454-1464
35. Lu, J., Getz, G., Miska, E. A., Alvarez-Saavedra, E., Lamb, J., Peck, D., Sweet-Cordero, A., Ebert, B. L., Mak, R. H., Ferrando, A. A., Downing, J. R., Jacks, T., Horvitz, H. R., and Golub, T. R. (2005) MicroRNA expression profiles classify human cancers. Nature 435, 834-838
36. Schantz, S. P., and Yu, G. P. (2002) Head and neck cancer incidence trends in young Americans, 1973-1997, with a special analysis for tongue cancer. Arch. Otolaryngol. Head Neck Surg. 128, 268-274
37. Shiboski, C. H., Shiboski, S. C., and Silverman, S., Jr. (2000) Trends in oral cancer rates in the United States, 1973-1996. Community Dent. Oral Epidemiol. 28, 249-256
38. Hiratsuka, H., Miyakawa, A., Nakamori, K., Kido, Y., Sunakawa, H., and Kohama, G. (1997) Multivariate analysis of occult lymph node metastasis as a prognostic indicator for patients with squamous cell carcinoma of the oral cavity. Cancer 80, 351-356
39. Take, Y., Umeda, M., Teranobu, O., and Shimada, K. (1999) Lymph node metastases in hamster tongue cancer induced with 9,10-dimethyl-1,2- benzanthracene. Association between histological findings and the incidence of neck metastases, and the clinical implications for patients with tongue cancer. Br. J. Oral Maxillofac. Surg. 37, 29-36
40. Reddy, S. P., Raslan, W. F., Gooneratne, S., Kathuria, S., and Marks, J. E. (1995) Prognostic significance of keratinization in nasopharyngeal carcinoma. Am. J. Otolaryngol. 16, 103-108
41. Gimenez-Conti, I. B., Shin, D. M., Bianchi, A. B., Roop, D. R., Hong, W. K., Conti, C. J., and Slaga, T. J. (1990) Changes in keratin expression during 7,12-dimethylbenz[a]anthracene-induced hamster cheek pouch carcinogenesis. Cancer Res. 50, 4441-4445
42. Li, J., Huang, H., Sun, L., Yang, M., Pan, C., Chen, W., Wu, D., Lin, Z., Zeng, C., Yao, Y., Zhang, P., and Song, E. (2009) MiR-21 indicates poor prognosis in tongue squamous cell carcinomas as an apoptosis inhibitor. Clin. Cancer Res. 15, 3998-4008
43. Saydam, O., Senol, O., Würdinger, T., Mizrak, A., Ozdener, G. B., Stemmer- Rachamimov, A. O., Yi, M., Stephens, R. M., Krichevsky, A. M., Saydam, N., Brenner, G. J., and Breakefield, X. O. (2011) miRNA-7 attenuation in Schwannoma tumors stimulates growth by up-regulating three oncogenic signaling pathways. Cancer Res. 71, 852-861
44. Zhao, X., Dou, W., He, L., Liang, S., Tie, J., Liu, C., Li, T., Lu, Y., Mo, P., Shi, Y., Wu, K., Nie, Y., and Fan, D. (2012) MicroRNA-7 functions as an antimetastatic microRNA in gastric cancer by targeting insulin-like growth factor-1 receptor. Oncogene, in press
45. Webster, R. J., Giles, K. M., Price, K. J., Zhang, P. M., Mattick, J. S., and Leedman, P. J. (2009) Regulation of epidermal growth factor receptor signaling in human cancer cells by microRNA-7. J. Biol. Chem. 284, 5731-5741
46. Reddy, S. D., Ohshiro, K., Rayala, S. K., and Kumar, R. (2008) MicroRNA-7, a homeobox D10 target, inhibits p21-activated kinase 1 and regulates its functions. Cancer Res. 68, 8195-8200
47. Kent, O. A., and Mendell, J. T. (2006) A small piece in the cancer puzzle. MicroRNAs as tumor suppressors and oncogenes. Oncogene 25, 6188-6196
48. Kefas, B., Godlewski, J., Comeau, L., Li, Y., Abounader, R., Hawkinson, M., Lee, J., Fine, H., Chiocca, E. A., Lawler, S., and Purow, B. (2008) microRNA-7 inhibits the epidermal growth factor receptor and the Akt pathway and is down-regulated in glioblastoma. Cancer Res. 68, 3566-3572
49. Foekens, J. A., Sieuwerts, A. M., Smid, M., Look, M. P., de Weerd, V., Boersma, A. W., Klijn, J. G., Wiemer, E. A., and Martens, J. W. (2008) Four miRNAs associated with aggressiveness of lymph node-negative, estrogen receptor-positive human breast cancer. Proc. Natl. Acad. Sci. U.S.A. 105, 13021-13026
50. Chou, Y. T., Lin, H. H., Lien, Y. C., Wang, Y. H., Hong, C. F., Kao, Y. R., Lin, S. C., Chang, Y. C., Lin, S. Y., Chen, S. J., Chen, H. C., Yeh, S. D., and Wu, C. W. (2010) EGFR promotes lung tumorigenesis by activating miR-7 through a Ras/ERK/Myc pathway that targets the Ets2 transcriptional repressor ERF. Cancer Res. 70, 8822-8831
51. Hu, S. J., Ren, G., Liu, J. L., Zhao, Z. A., Yu, Y. S., Su, R. W., Ma, X. H., Ni, H., Lei, W., and Yang, Z. M. (2008) MicroRNA expression and regulation in mouse uterus during embryo implantation. J. Biol. Chem. 283, 23473-23484
52. Gabriely, G., Wurdinger, T., Kesari, S., Esau, C. C., Burchard, J., Linsley, P. S., and Krichevsky, A. M. (2008) MicroRNA 21 promotes glioma invasion by targeting matrix metalloproteinase regulators. Mol. Cell Biol. 28, 5369-5380
53. Loayza-Puch, F., Yoshida, Y., Matsuzaki, T., Takahashi, C., Kitayama, H., and Noda, M. (2010) Hypoxia and RAS-signaling pathways converge on, and cooperatively down-regulate, the RECK tumor-suppressor protein through microRNAs. Oncogene 29, 2638-2648
54. Zhang, Z., Li, Z., Gao, C., Chen, P., Chen, J., Liu, W., Xiao, S., and Lu, H. (2008) miR-21 plays a pivotal role in gastric cancer pathogenesis and progression. Lab. Invest. 88, 1358-1366
55. Nagini, S., Letchoumy, P. V., A, T., and Cr, R. (2009) Of humans and hamsters. A comparative evaluation of carcinogen activation, DNA damage, cell proliferation, apoptosis, invasion, and angiogenesis in oral cancer patients and hamster buccal pouch carcinomas. Oral Oncol. 45, e31-37